Roche (RHHBY) announced the CE certification of the new cobas 6800/8800 systems 2.0. The update significantly enhances the efficiency of laboratories by optimizing resources, reducing downtime, consolidating test menus, and increasing throughput. These improvements promise a more streamlined diagnostics experience for healthcare professionals and their patients. Laboratories can now perform a wider range of tests on a single solution, simplifying laboratory logistics and helping to optimize the use of resources.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RHHBY:
- Roche Vabysmo PFS approved in EU for three retinal conditions
- Genentech presents updated fixed-duration Columvi and Lunsumio data at ASH
- Roche commences tender offer for outstanding Poseida shares at $9 per share
- Roche says five-year results confirm Polivy combo as ‘new standard of care’
- Genentech announces FDA acceptance of Columvi combination sBLA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
